Soleil Upgrades THC To Buy

Analysts at Soleil upgrade Tenet Healthcare Corporation (NYSE: THC) from “gradually accumulate” to “buy.” The target price for THC has been raised from $6 to $8.

THC shares rose 0.91% to close at $6.66 on Friday.

More Analyst Ratings here